Post Holdings Reports Results for the First Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook
ST. LOUIS, Feb. 01, 2024 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported […]
ARCA biopharma Announces 2023 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options […]
TriumphPay Announces Addition of Two New Hires to Sales Leadership Team
DALLAS, Feb. 01, 2024 (GLOBE NEWSWIRE) — TriumphPay, the payments network for the freight transportation industry, today announced the addition […]
Advisory: Fortis Inc. to Hold Teleconference and Webcast on February 9 to Discuss 2023 Annual Results
ST. JOHN’S, Newfoundland and Labrador, Feb. 01, 2024 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS) will […]
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel […]
Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference
NEW HAVEN, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]
Southside Bancshares, Inc. Increases and Declares Cash Dividend
TYLER, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) — The Board of Directors of Southside Bancshares, Inc., (NASDAQ:SBSI), parent company of […]
Glacier Bancorp Completes Acquisition of Community Financial Group, Inc. in Spokane, Washington
KALISPELL, Mont., Feb. 01, 2024 (GLOBE NEWSWIRE) — Glacier Bancorp, Inc. (“Glacier”) (NYSE: GBCI), today announced the completion of its […]
Gray and Marquee Broadcasting Swap Television Station Assets
ATLANTA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray” or the “Company”) (NYSE: GTN) announced today that it […]
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
PHILADELPHIA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and […]
